Covid vaccination for all above 18: Government to open registration on CoWin portal from April 24 | India News – Times of India

0
522

[google-translator]

NEW DELHI: The government has announced that it is opening the process of vaccine registrations for all above 18 from April 24 onwards. All those eligible can register on Co-Win portal, cowin.gov.in.
On Monday, the decision to extend vaccination to all adults in the country was taken at a high-level review meeting chaired by Prime Minister Modi. Vaccination shall continue as before in government vaccination centres, provided free of cost to the eligible population above 45 years of age. States can procure Covid vaccine doses directly from manufacturers, the government said.
This will be phase 3 of the vaccination drive in India, which started on January 15.
The government from its share will allocate vaccines to states/UTs based on the criteria of the extent of infection (number of active Covid cases) and performance (speed of administration). States can procure Covid vaccine doses directly from manufacturers, says Centre.
On Wednesday, Serum Institute of India (SII) announced that Covishield will be sold at Rs 400 per dose to the state government and Rs 600 to private hospitals. Covishield is known as AstraZeneca vaccine across the world.
SII, an Indian biotechnology and pharmaceuticals company, issued a statement after the government allowed vaccination of all persons above the age of 18. “The promising directives will help to scale up vaccine production, and allow state governments, private hospitals, and vaccination centers to procure vaccines directly,” Serum chief Adar Poonawalla said welcoming the move.
He also said that for the next two months, they will address the limited capacity by scaling up the vaccine production. “Going ahead, 50 per cent of our capacities will be served to the Government of India’s vaccination programme, and the remaining 50 per cent of of the capacity will be for the State governments and private hospitals,” the company said.The company also stated that considering the global vaccine prices which cost anywhere from Rs 750 to Rs 1,500 per dose, they are ensuring that vaccines are affordable in India in comparison to any other vaccines in the world.
In the next four to five months, the vaccines will be made available in retail and free trade.

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here